Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Biochemistry

• Publication date

  1997-12-02

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI971843EPMID 9398206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2H and 31P NMR study of pentalysine interaction with headgroup deuterated phosphatidylcholine and phosphatidylserine

  2004cited by this paper
• Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes.

  1997cited by this paper
• Anionic phospholipids modulate peptide insertion into membranes.

  1997cited by this paper
• Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity.

  1997cited by this paper
• Folding proteins into membranes

  1996cited by this paper
• Crossing the Hydrophobic Barrier--Insertion of Membrane Proteins

  1996cited by this paper
• Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis.

  1996cited by this paper
• Fusogenic Properties of the C-terminal Domain of the Alzheimer β-Amyloid Peptide*

  1996cited by this paper
• Binding of hisactophilin I and II to lipid membranes is controlled by a pH-dependent myristoyl-histidine switch.

  1996cited by this paper
• Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence.

  1996cited by this paper
• The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide*

  1996cited by this paper
• Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.

  1996cited by this paper
• Experimentally determined hydrophobicity scale for proteins at membrane interfaces

  1996cited by this paper
• Binding of small basic peptides to membranes containing acidic lipids: theoretical models and experimental results.

  1996cited by this paper
• Binding of substance P agonists to lipid membranes and to the neurokinin-1 receptor.

  1996cited by this paper
• Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment.

  1996cited by this paper
• The toxicity in vitro of beta-amyloid protein.

  1995cited by this paper
• 1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence.

  1995cited by this paper
• Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's disease.

  1995cited by this paper
• Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.

  1995cited by this paper
• Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

  1995cited by this paper
• Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation.

  1994cited by this paper
• Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35).

  1994cited by this paper
• Theoretical models of the ion channel structure of amyloid beta-protein.

  1994cited by this paper
• Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease.

  1994cited by this paper
• Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.

  1994cited by this paper
• Binding of apolipoprotein A-I model peptides to lipid bilayers. Measurement of binding isotherms and peptide-lipid headgroup interactions.

  1994cited by this paper
• Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein.

  1994cited by this paper
• Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes.

  1994cited by this paper
• Solution structure of residues 1-28 of the amyloid beta-peptide.

  1994cited by this paper
• Thermodynamic characterization of the association of small basic peptides with membranes containing acidic lipids.

  1993cited by this paper
• Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction.

  1993cited by this paper
• Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.

  1993cited by this paper
• Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum.

  1993cited by this paper
• Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

  1993cited by this paper
• Receptor-mediated specific biological activity of a beta-amyloid protein fragment for NK-1 substance P receptors.

  1993cited by this paper
• Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.

  1993cited by this paper
• Interaction of amyloid beta protein (25-35) with tachykinin receptors.

  1992cited by this paper
• In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information.

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Electrostatics and reduction of dimensionality produce apparent cooperativity when basic peptides bind to acidic lipids in membranes.

  1992cited by this paper
• Binding of basic peptides to acidic lipids in membranes: effects of inserting alanine(s) between the basic residues.

  1992cited by this paper
• NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.

  1992cited by this paper
• Influence of stigmastanol and stigmastanyl-phosphorylcholine, two plasma cholesterol lowering substances, on synthetic phospholipid membranes. A 2H- and 31P-NMR study.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor.

  1991cited by this paper
• Binding of peptides with basic residues to membranes containing acidic phospholipids.

  1991cited by this paper
• Interaction of charged and uncharged calcium channel antagonists with phospholipid membranes. Binding equilibrium, binding enthalpy, and membrane location.

  1991cited by this paper
• The molecular pathology of Alzheimer's disease.

  1991cited by this paper
• An unusual peptide conformation may precipitate amyloid formation in Alzheimer's disease: application of solid-state NMR to the determination of protein secondary structure.

  1991cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• Melittin binding to mixed phosphatidylglycerol/phosphatidylcholine membranes.

  1990cited by this paper
• Binding of a neuropeptide, substance P, to neutral and negatively charged lipids.

  1989cited by this paper
• Electric charge effects on phospholipid headgroups. Phosphatidylcholine in mixtures with cationic and anionic amphiphiles.

  1989cited by this paper
• Interaction of melittin with phosphatidylcholine membranes. Binding isotherm and lipid head-group conformation.

  1989cited by this paper
• Partitioning of local anesthetics into membranes: surface charge effects monitored by the phospholipid head-group.

  1988cited by this paper
• Anion binding to neutral and positively charged lipid membranes.

  1988cited by this paper
• Phospholipid head groups as sensors of electric charge in membranes.

  1987cited by this paper
• Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers.

  1987cited by this paper
• Structure and dynamics of the phosphatidylcholine and the phosphatidylethanolamine head group in L‐M fibroblasts as studied by deuterium nuclear magnetic resonance.

  1987cited by this paper
• Calculation of protein conformation from circular dichroism.

  1986cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Headgroup interactions in mixed phospholipid bilayers.

  1983cited by this paper
• Lipid solvation of cytochrome c oxidase. Deuterium, nitrogen-14, and phosphorus-31 nuclear magnetic resonance studies on the phosphocholine head group and on cis-unsaturated fatty acyl chains.

  1983cited by this paper
• Interaction of metal ions with phosphatidylcholine bilayer membranes.

  1981cited by this paper
• Molecular details of anesthetic--lipid interaction as seen by deuterium and phosphorus-31 nuclear magnetic resonance.

  1981cited by this paper
• Influence of cholesterol on the polar region of phosphatidylcholine and phosphatidylethanolamine bilayers.

  1978cited by this paper
• 31P nuclear magnetic resonance and the head group structure of phospholipids in membranes.

  1978cited by this paper
• Molecular order in cis and trans unsaturated phospholipid bilayers.

  1978cited by this paper
• Deuterium magnetic resonance: theory and application to lipid membranes

  1977cited by this paper
• Phosphorus-31 chemical shift anisotropy in unsonicated phospholipid bilayers.

  1976cited by this paper

• Molecular mechanisms associated with the interaction of external electromagnetic fields in protein dynamics and aggregation: a focus on amyloid-β peptide

  2025cites this paper
• Effect of amyloid-beta 1-40 and 1-42 peptides on the lateral diffusion and signaling of receptor for advanced glycation endproducts (RAGE).

  2025cites this paper
• The structure of amyloid-β (1-42) oligomers in membrane-mimetic environments.

  2025cites this paper
• The molecular electrometer at 40.

  2025cites this paper
• Understanding Aβ Peptide Binding to Lipid Membranes: A Biophysical Perspective

  2024influential citation
• Depth-profiling alkyl chain order in unsaturated lipid monolayers on water.

  2024cites this paper
• β-Hairpin Alignment Alters Oligomer Formation in Aβ-Derived Peptides

  2024cites this paper
• Modulation of Alzheimer’s Disease Aβ40 Fibril Polymorphism by the Small Heat Shock Protein αB-Crystallin

  2024cites this paper
• NMR studies of amyloid interactions.

  2024cites this paper
• Sugar distributions on gangliosides guide the formation and stability of amyloid-β oligomers.

  2023cites this paper
• Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases.

  2023cites this paper
• Sugar distributions on gangliosides guide the formation and stability of amyloid-β oligomers

  2023cites this paper
• The co-effect of copper and lipid vesicles on Aβ aggregation.

  2022cites this paper
• Exogenous Aβ1-42 monomers improve synaptic and cognitive function in Alzheimer's disease model mice.

  2022cites this paper
• Tuning the surface charge of phospholipid bilayers inhibits insulin fibrilization.

  2022cites this paper
• Molecular mechanisms of direct and indirect interplay between amyloid β42 oligomer and characteristic lipids

  2022cites this paper
• Physical Mechanism of Amyloid-β Peptide Chain Aggregation on Fluidic Lipid Nanotubules.

  2022cites this paper
• Ganglioside enriched phospholipid vesicles induce cooperative Aβ oligomerization and membrane disruption

  2022cites this paper
• Approaches for a Closer Look at Problems of Liquid Membranes with Amyloid-Beta Peptides

  2021cites this paper
• Assessment of the impact of nanoparticles on the activity of biomimetic membrane

  2021cites this paper
• Exploring interactions between lipids and amyloid-forming proteins: a review for applying fluorescence and NMR techniques.

  2021cites this paper
• Defining the Neuropathological Aggresome across in Silico, in Vitro, and ex Vivo Experiments.

  2021cites this paper
• Application of DNP-enhanced solid-state NMR to studies of amyloid-β peptide interaction with lipid membranes.

  2021cites this paper
• Biophysical characteristics of lipid‐induced Aβ oligomers correlate to distinctive phenotypes in transgenic mice

  2021cites this paper
• The kinetics of islet amyloid polypeptide phase-separated system and hydrogel formation are critically influenced by macromolecular crowding

  2021cites this paper
• A unifying framework for amyloid-mediated membrane damage: The lipid-chaperone hypothesis.

  2021cites this paper
• The amyloidogenic peptide amyloid beta(16-22) displays facet dependent conformation on metal surfaces

  2021cites this paper
• Mixed Phospholipid Vesicles Catalytically Inhibit and Reverse Amyloid Fibril Formation.

  2020cites this paper
• Seeding and Growth of β-Amyloid Aggregates upon Interaction with Neuronal Cell Membranes

  2020cites this paper
• Evidence for aggregation-independent, PrPC-mediated Aβ cellular internalization

  2020cites this paper
• Amyloidogenic Intrinsically Disordered Proteins: New Insights into Their Self-Assembly and Their Interaction with Membranes

  2020cites this paper
• Nanoscale Interplay of Membrane Composition and Amyloid Self-Assembly.

  2020cites this paper
• Aβ-AMYLOID FIBRILS ARE SELF-TRIGGERED BY THE INTERFACIAL LIPID ENVIRONMENT AND LOW PEPTIDE CONTENT.

  2020cites this paper
• Structural and mechanistic insights into the inhibition of amyloid-β aggregation by Aβ39-42 fragment derived synthetic peptides.

  2020cites this paper
• Acetylation of Aβ40 alters aggregation in the presence and absence of lipid membranes.

  2019cites this paper
• Metal binding to the amyloid-β peptides in the presence of biomembranes: potential mechanisms of cell toxicity

  2019cites this paper
• Investigation into the effect of fatty acids on the yield and replication of rotavirus in cell culture

  2019cites this paper
• Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts

  2019cites this paper
• Chirality Dependence of Amyloid β Cellular Uptake and a New Mechanistic Perspective

  2019cites this paper
• Self-assembly of amino acid-based random copolymers for antibacterial application and infection treatment as nanocarriers.

  2019cites this paper
• Circular-Dichroism and Synchrotron-Radiation Circular-Dichroism Spectroscopy as Tools to Monitor Protein Structure in a Lipid Environment.

  2019cites this paper
• Revealing a Dual Role of Ganglioside Lipids in the Aggregation of Membrane-Associated Islet Amyloid Polypeptide

  2019cites this paper
• Rhombohedral trap for studying molecular oligomerization in membranes: application to daptomycin.

  2019cites this paper
• De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer

  2019cites this paper
• Amyloid-β Peptide-Lipid Bilayer Interaction investigated by Supercritical Angle Fluorescence.

  2019cites this paper
• Structure and Physicochemical Properties of Aβ42 Tetramer: Multi-Scale Molecular Dynamics Simulations.

  2019cites this paper
• Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways

  2019cites this paper
• Hydrogen peroxide modifies Aβ-membrane interactions with implications for Aβ40 aggregation.

  2019cites this paper
• Pathways of amyloid-beta absorption and aggregation in a membranous environment.

  2019cites this paper
• Membrane-mimetic systems for biophysical studies of the amyloid-β peptide.

  2019cites this paper
• Molecular insights into amyloid toxicity using model lipid membranes

  2019cites this paper
• Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

  2018cites this paper
• Amyloidogenicity and Cytotoxicity of a Recombinant C-Terminal His6-Tagged Aβ1-42.

  2018cites this paper
• Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform

  2018cites this paper
• Multiphasic effect of vinyl pyrrolidone polymers on amyloidogenesis, from macromolecular crowding to inhibition.

  2018cites this paper
• Evidence from ITIR-FCS Diffusion Studies that the Amyloid-Beta (Aβ) Peptide Does Not Perturb Plasma Membrane Fluidity in Neuronal Cells.

  2018cites this paper
• A Mechanistic Understanding of Self-Propagating Amyloid-β Oligomer Conformations in Alzheimer Disease

  2018cites this paper
• Binding of Cytotoxic Aβ25-35 Peptide to the Dimyristoylphosphatidylcholine Lipid Bilayer

  2018cites this paper
• TMPyP Inhibits Amyloid-β Aggregation and Alleviates Amyloid-Induced Cytotoxicity

  2017cites this paper
• Chiral Plasmonic Nanochains via the Self-Assembly of Gold Nanorods and Helical Glutathione Oligomers Facilitated by Cetyltrimethylammonium Bromide Micelles.

  2017cites this paper
• Design, Synthesis and Biological Assessment of Ferulic Acid Derivatives as Inhibitors of β-Amyloid Oligomerization in Alzheimer’s Disease

  2017cites this paper
• Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.

  2017cites this paper
• Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry.

  2017cites this paper
• Investigation of the multi-domain aggregation mechanism of ataxin-3

  2017cites this paper
• Glucose directs amyloid-beta into membrane-active oligomers.

  2017cites this paper
• Inhibition of lysozyme amyloidogenesis by phospholipids. Focus on long-chain dimyristoylphosphocholine.

  2017cites this paper
• Inclusion of lipopeptides into the DMPC lipid bilayers prevents Aβ peptide insertion.

  2017cites this paper
• Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease

  2017cites this paper
• Structural insights of a self-assembling 9-residue peptide from the C-terminal tail of the SARS corona virus E-protein in DPC and SDS micelles: A combined high and low resolution spectroscopic study

  2017cites this paper
• Molecular Understanding of Aβ-hIAPP Cross-Seeding Assemblies on Lipid Membranes.

  2017cites this paper
• Amyloid Beta Peptide Folding in Reverse Micelles.

  2017cites this paper
• Investigating the Formation and Structure of Amyloid Fibrils in Solution and on Surface

  2017cites this paper
• Cholesterol Changes the Mechanisms of Aβ Peptide Binding to the DMPC Bilayer

  2017cites this paper
• Chapter 10 Structure and Function of Stefin B Oligomers – Important Role in

  2017cites this paper
• Distinct Membrane Disruption Pathways Are Induced by 40-Residue β-Amyloid Peptides*

  2016influential citation
• Metabolite amyloids: a new paradigm for inborn error of metabolism disorders

  2016cites this paper
• Neutron Scattering Studies of the Interplay of Amyloid β Peptide(1–40) and An Anionic Lipid 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol

  2016cites this paper
• Targeting Fat: Mechanisms of Protein Localization to Lipid Droplets.

  2016cites this paper
• The Alzheimer's disease Aβ peptide binds to the anionic DMPS lipid bilayer.

  2016cites this paper
• Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets.

  2016cites this paper
• Solvent Removal Induces a Reversible β-to-α Switch in Oligomeric Aβ Peptide.

  2016cites this paper
• From a pro-apoptotic peptide to a lytic peptide: One single residue mutation.

  2016cites this paper
• Protein/Peptide Aggregation and Amyloidosis on Biointerfaces

  2016cites this paper
• Membrane binding of peptide models for early stages of amyloid formation: Lipid packing counts more than charge.

  2016cites this paper
• Polyoxometalate-Driven Self-Assembly of Short Peptides into Multivalent Nanofibers with Enhanced Antibacterial Activity.

  2016cites this paper
• High-Affinity Binding of Monomeric but Not Oligomeric Amyloid-β to Ganglioside GM1 Containing Nanodiscs.

  2016cites this paper
• Functional modulation of strychnine-sensitive glycine receptors in rat hippocampal pyramidal neurons by amyloid-β protein (1-42).

  2016cites this paper
• Hematoxylin Inhibits Amyloid β-Protein Fibrillation and Alleviates Amyloid-Induced Cytotoxicity.

  2016cites this paper
• Membrane-Induced Dichotomous Conformation of Amyloid β with the Disordered N-Terminal Segment Followed by the Stable C-Terminal β Structure

  2016cites this paper
• Amyloid Fibril Nucleation In Reverse Micelles

  2015cites this paper
• The Role of Langmuir Monolayers To Understand Biological Events

  2015cites this paper
• Lipids in Amyloid-β Processing, Aggregation, and Toxicity.

  2015cites this paper
• All-Atom Explicit-Solvent Replica-Exchange Molecular Dynamics Simulations of the Alzheimer’s Disease Aβ Monomer

  2015cites this paper
• Competition between Fibrillation and Induction of Vesicle Fusion for the Membrane-Associated 40-Residue β-Amyloid Peptides.

  2015cites this paper
• Membrane Curvature-Sensing and -Inducing Activity of Islet Amyloid Polypeptide and Its Implications for Membrane Disruption*

  2015cites this paper
• Tabersonine inhibits amyloid fibril formation and cytotoxicity of Aβ(1-42).

  2015cites this paper
• Model Neural Membrane Droplet Interface Bilayers from Brain Total Lipid Extract for Studying Membrane-Peptide Interactions with Amyloid-β

  2015cites this paper
• Membrane Curvature-sensing and Curvature-inducing Activity of Islet Amyloid Polypeptide and Its Implications for Membrane Disruption*♦

  2015cites this paper
• Influence of sequence and lipid type on membrane perturbation by human and rat amyloid β-peptide (1-42).

  2015cites this paper
• Ca(2+) Interacts with Glu-22 of Aβ(1-42) and Phospholipid Bilayers to Accelerate the Aβ(1-42) Aggregation Below the Critical Micelle Concentration.

  2015cites this paper